Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts

NCT06055777 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
64
Enrollment
INDUSTRY
Sponsor class

Stopped Due to the termination criteria for dose escalation in the clinical protocol having been reached, this trial is terminated.

Conditions

Interventions

Sponsor

Suzhou Erye Pharmaceutical Co., Ltd.